RLF AgTech secures commercial adoption after trials
- RLF AgTech achieved significant commercial adoption of its plant nutrition products after completing three seasons of field trials.
- The company's stock responded positively to the announcement, gaining over 11% during morning trading.
- The business intends to expand this repeatable commercial model to additional agricultural growers across the country.
RLF AgTech (ASX:RLF) secured commercial adoption of its crop nutrition products with a large domestic corporate grower following three seasons of paddock trials.
The milestone follows consecutive years of field testing to validate the performance of biology alongside conventional plant nutrition.
"The market is clearly moving towards biology working alongside conventional nutrition, and we've spent the past three seasons proving that out in the paddock with one of the country's larger corporate growers," said RLF AgTech CEO Stuart Upton.
The company stated that the expanded programme provides a repeatable model to target other agricultural producers while evaluating local manufacturing opportunities.
Following the announcement, the RLF AgTech share price was up at $0.04.
The strategic commercial expansion follows the recent relocation of the company's principal administrative office to Kyneton, Victoria.
